Valentin Sotov

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Journal: Frontiers in oncology

Published: May 09, 2026

Elucidating divergent biology in uterine carcinosarcoma.

Elucidating divergent biology in uterine carcinosarcoma.

Journal: Translational oncology

Published: February 27, 2025

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma.

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma.

Journal: Genome medicine

Published: December 30, 2024

Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer.

Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer.

Journal: Science advances

Published: October 30, 2024

Neurodevelopmental hijacking of oligodendrocyte lineage programs drives glioblastoma infiltration.

Neurodevelopmental hijacking of oligodendrocyte lineage programs drives glioblastoma infiltration.

Journal: Developmental cell

Published: August 31, 2024

Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy.

Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy.

Journal: Nature communications

Published: March 14, 2024

Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liver.

Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liver.

Journal: The Journal of clinical investigation

Published: August 29, 2023

Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.

Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.

Journal: Cancers

Published: May 25, 2023

Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab.

Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab.

Journal: Current oncology (Toronto, Ont.)

Published: July 10, 2019

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

Journal: Journal for immunotherapy of cancer

Published: December 18, 2018

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.

Journal: Cancer immunology, immunotherapy : CII

Published: June 07, 2018

Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma.

Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma.

Journal: JAMA oncology

Published: November 18, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026